SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-043665
Filing Date
2023-12-05
Accepted
2023-12-05 08:45:13
Documents
17
Period of Report
2023-12-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50220
2 ex10-1.htm EX-10.1 9470
3 ex99-1.htm EX-99.1 19315
4 ex10-1_001.jpg GRAPHIC 28709
5 ex99-1_002.jpg GRAPHIC 30674
  Complete submission text file 0001493152-23-043665.txt   391384

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE biaf-20231201.xsd EX-101.SCH 3785
7 XBRL DEFINITION FILE biaf-20231201_def.xml EX-101.DEF 26626
8 XBRL LABEL FILE biaf-20231201_lab.xml EX-101.LAB 36689
9 XBRL PRESENTATION FILE biaf-20231201_pre.xml EX-101.PRE 25250
11 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5312
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41463 | Film No.: 231465304
SIC: 8731 Services-Commercial Physical & Biological Research